2017_05_18_Denali Company Photo.jpg
Flutes.png
photo-1425036458755-dc303a604201.jpeg
Denali_1.jpg
2017_05_18_Denali Company Photo.jpg

PEOPLE


We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.

SCROLL DOWN

PEOPLE


We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.

Flutes.png

FOUNDERS


Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and founding investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines.

FOUNDERS


Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and founding investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines.

photo-1425036458755-dc303a604201.jpeg

BOARD OF DIRECTORS


Success is accelerated by experience, collaboration and leadership. Denali’s Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.

Denali_1.jpg

SCIENTIFIC ADVISORY BOARD


Denali is collaborating with some of the brightest minds in academia and industry to defeat degeneration.